Revenue Dynamics YoY (Last Twelve Months): ARS Pharmaceuticals (SPRY)

Graphic logo of ARS Corp (SPRY)

A stable team of experts supports the development of ARS Pharmaceuticals (SPRY). The company is creating Neffy, a needle-free spray to combat anaphylaxis, by investing in R&D. The year-over-year percentage change in sales volume for the LTM confirms the growth trajectory, where -14.30 serves as the current metric level. However, success depends on insurance provider recognition of the drug and the willingness of physicians to move away from traditional injections.

Revenue Growth YoY (Last 12 Months): ARS Pharmaceuticals Inc (SPRY) for 02/11/2024 - 11/17/2026

ARS Pharmaceuticals, Inc. (SPRY) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:SPRY (ARS Corp)
Finished products of ars-pharma.com

The commercial success of ARS Pharmaceuticals (SPRY) depends directly on scaling sales of the Neffy spray, as reflected in the year-over-year (LTM) gross revenue dynamics. This indicator measures the percentage growth of trailing twelve-month revenue, allowing for an assessment of the drug's expansion efficiency through prescription rates and insurance coverage, where sharp growth spikes may signal a temporary reduction in margins to capture market share.

Competitors of ARS Pharmaceuticals (SPRY)

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TBPH|AQST (Aquestive Corp) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) scPharmaceuticals Inc. (SCPH)|Revenue Growth YoY (Last 12 Months) TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)